Skip to content

Cerebrospinal Fluid Gravity Correlation Analysis

Correlation Between Blood Biochemical Indicators and Cerebrospinal Fluid Gravity in Aged Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05644535
Enrollment
80
Registered
2022-12-09
Start date
2022-12-01
Completion date
2023-05-31
Last updated
2022-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrospinal Fluid, Specific Gravity

Keywords

Cerebrospinal fluid, Correlation Analysis, Lighter Specific Gravity

Brief summary

The purpose of this study was to measure cerebrospinal fluid density in aged patients and to see if there was a correlation between these factors and cerebrospinal fluid density by using the electronic medical record system to understand the patient's gender, blood glucose, blood biochemical electrolytes and blood levels.

Detailed description

Hip joint injury is one of the common injuries in the elderly, and hip arthroplasty is a treatment method that allows patients to get out of bed and return to social life as soon as possible. Currently, the common position for hip arthroplasty is the lateral position; and combined spinal and epidural anesthesia or subarachnoid anesthesia is also the common anesthesia method for hip arthroplasty. In the lateral position, the patient's affected limb is often on top and the healthy limb is on the bottom; the healthy side position is also the usual position for hip arthroplasty. In this position, it may be optimal to use a lighter specific gravity local anesthetic drug because it tends to anesthetize only the upper affected limb and does not require a return to the supine position after anesthesia due to changes in the plane of block, minimizing pain and hemodynamic fluctuations during anesthesia and position changes. Currently, light specific gravity is more of a concept. Because in the available data, only the range of cerebrospinal fluid density of ordinary healthy adults is available, there is little literature and data to describe and analyze what the cerebrospinal fluid density of elderly patients actually is. Therefore, when we administer subarachnoid anesthesia to elderly patients, we cannot determine whether the dispensed local anesthetic drug is a light specific gravity. In this study, we intend to collect cerebrospinal fluid from elderly patients who underwent hip arthroplasty under combined lumbar and rigid anesthesia or subarachnoid anesthesia, and measure the cerebrospinal fluid density in elderly patients, and observe whether there is a correlation between the above factors and cerebrospinal fluid density through the electronic medical record system to understand the patient's gender, blood glucose, blood biochemical electrolytes and routine blood levels; thus, we can better guide the use of lighter specific gravity drugs in clinical practice.

Interventions

DIAGNOSTIC_TESTCerebrospinal fluid densitometry

After obtaining the patient's cerebrospinal fluid specimen, the actual mass of the cerebrospinal fluid was measured by pipetting 1000 μL of cerebrospinal fluid specimen on an analytical balance using a pipette gun, and all specimens were measured three times and the average of the three times was taken as the final mass of 1000 μL of that specimen. After the mass measurement, the residual cerebrospinal fluid was disposed of as medical waste. The density of each specimen was obtained according to the density to mass conversion formula ρ=m/v.

DIAGNOSTIC_TESTblood routine examination

After obtaining the patient's blood specimens, they were sent to the laboratory for blood routine examination.

DIAGNOSTIC_TESTBlood electrolyte examination

After obtaining the patient's blood specimens, they were sent to the laboratory for blood electrolyte examination.

Sponsors

First People's Hospital of Chenzhou
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Receiving combined spinal and epidural anesthesia or subarachnoid anesthesia ASA Ⅰ or Ⅱ patients No significant neurological pathology No recent history of cerebral infarction No recent history of cerebral hemorrhage No central nervous system inflammation No spinal inflammatory disease No history of spinal surgery Patients who have given pre-operative informed written consent

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Cerebrospinal fluid densitybaseline (before anesthesia)After obtaining the mass of cerebrospinal fluid, the density was calculated from ρ=m/v

Secondary

MeasureTime frameDescription
Plasma K+ concentrationbaseline (before anesthesia)Plasma K+ concentration
Plasma Cl- concentrationbaseline (before anesthesia)Plasma Cl- concentration
WBCbaseline (before anesthesia)Leukocyte concentration in blood
Blood sugarbaseline (before anesthesia)Plasma glucose level
Lymphocyte concentration in bloodbaseline (before anesthesia)Lymphocyte concentration in blood
C-reactive protein (CRP)baseline (before anesthesia)C-reactive protein concentration in plasma
Neutrophil concentration in bloodbaseline (before anesthesia)Neutrophil concentration in blood

Countries

China

Contacts

Primary ContactZhiming Zhang
otc0735@163.com+8613875555649
Backup ContactYuan Qin
uscqinyuan@163.com13657381087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026